Full Med Adherence Reduces Costs for Patients With CVD

Share this content:
Full Med Adherence Reduces Costs for Patients With CVD
Full Med Adherence Reduces Costs for Patients With CVD

THURSDAY, Aug. 18, 2016 (HealthDay News) -- Full adherence to guideline-recommended therapies is associated with a reduced rate of major adverse cardiovascular events (MACE) and cost savings, according to a study published in the Aug. 23 issue of the Journal of the American College of Cardiology.

Sameer Bansilal, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues stratified patients hospitalized with myocardial infarction (MI) or atherosclerotic disease (ATH) as fully adherent, partially adherent, or nonadherent to statins and angiotensin-converting enzyme inhibitors. Data were included for 4,015 post-MI patients and 12,976 patients with ATH.

The researchers found that the fully adherent group had a significantly lower rate of MACE than the nonadherent and partially adherent groups in the post-MI cohort (hazard ratios, 0.73 and 0.81, respectively). For MI hospitalizations, the fully adherent group had reduced per-patient annual direct medical (ADM) costs of $369 and $440 compared with the partially and nonadherent groups, respectively. At two years, the fully adherent group had a significantly lower rate of MACE than the nonadherent and partially adherent groups (hazard ratios, 0.56 and 0.76, respectively) in the ATH cohort. Reduced per-patient ADM costs for MI hospitalizations were $371 and $907 for the fully adherent group versus the partially adherent and nonadherent groups, respectively.

"Novel approaches to improve adherence may significantly reduce cardiovascular events," the authors write.

Several authors disclosed being employees of Ferrer and Aetna.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »